CAR-T cells targeting CD19 and CD20
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CAR-T cells targeting CD19 and CD20, covering 2022-02-15 to 2022-02-15. Get the full timeline:
Most recent: Clinical Trial Update: T Cells Expressing Fully-human Anti-CD19 and Anti-CD20 Chimeric Antigen Receptors for Treating B-cell Malignancies and Hodgkin Lymphoma [Phase 1]